Revolution Medicines RVMD
NASDAQ RVMD
$199.86 +9.12 (+4.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) EBT (2019 - 2026)

Revolution Medicines (RVMD) posted EBT of -$644.4 million for Q2 2026, down 41.99% on a QoQ basis from -$453.8 million in Q1 2026, and down 160.05% year-over-year from $1.1 billion in Q2 2025.

Analysis

Revolution Medicines (RVMD) EBT (2019 - 2026) Analysis & Trends

Revolution Medicines has reported EBT for 8 years, with the latest figure at -$644.4 million in Q2 2026.

  • On a quarterly basis, EBT fell 160.05% year-over-year to -$644.4 million in Q2 2026; TTM through Jun 2026 was -$1.8 billion, a 117.55% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 88.28% from the prior year.
  • EBT was -$644.4 million for Q2 2026 at Revolution Medicines, down from -$453.8 million in the prior quarter.
  • The five-year high for EBT was -$56.6 million in Q4 2022, with the low at -$644.4 million in Q2 2026.
  • Average EBT over 5 years is -$195.6 million, with a median of -$144.8 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: EBT fell 7.51% in 2022, then tumbled 186.04% in 2023.
  • Over 5 years, EBT stood at -$56.6 million in 2022, then tumbled by 186.04% to -$162.0 million in 2023, then fell by 20.58% to -$195.3 million in 2024, then slumped by 86.82% to -$364.9 million in 2025, then tumbled by 76.59% to -$644.4 million in 2026.
  • The last three EBT figures came in at -$644.4 million (Q2 2026), -$453.8 million (Q1 2026), and -$364.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 6.75 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 4.28 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 2.80 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -10.25 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -653.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.39 Bn
10 Revolution Medicines 40.86 Bn 40.86 Bn - -644.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -644.37 Mn
Mar 31, 2026 -453.82 Mn
Dec 31, 2025 -364.89 Mn
Sep 30, 2025 -305.21 Mn
Jun 30, 2025 -247.79 Mn
Mar 31, 2025 -213.42 Mn
Dec 31, 2024 -195.32 Mn
Sep 30, 2024 -156.29 Mn
Jun 30, 2024 -133.23 Mn
Mar 31, 2024 -116.00 Mn
Dec 31, 2023 -161.99 Mn
Sep 30, 2023 -112.30 Mn
Jun 30, 2023 -98.30 Mn
Mar 31, 2023 -68.10 Mn
Dec 31, 2022 -56.63 Mn
Sep 30, 2022 -73.63 Mn
Jun 30, 2022 -61.22 Mn
Mar 31, 2022 -57.65 Mn
Dec 31, 2021 -52.68 Mn
Sep 30, 2021 -52.94 Mn
API Access

Revolution Medicines EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=RVMD&period=max&api_key=YOUR_API_KEY